Wall Street Journal : Approval of Eli Lilly’s New Alzheimer’s Drug Will Accelerate New Era of Treatment

 

#Business #WallStreet

With the arrival of Lilly’s Kisunla, Alzheimer’s care could become more like treatment of cancer and rheumatoid arthritis and their regular infusions.

Read More  

WSJ.com: US Business  

PAID 

This is a business article located in the U.S. Business section of the Wall Street Journal. For the latest articles on U.S. business, current markets and other business related news follow our Twitter Page or bookmark this website.

Leave a Reply

Generated by Feedzy